RAMIZ ELIAS: Open Payments
NPI 1417164518 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,451 in 48 payments from 15 companies in 2025. Trend: 2023 $1,251 · 2024 $1,772 · 2025 $1,451
Food & beverage: $1,408Education: $43
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $374 |
| GlaxoSmithKline, LLC. | 6 | $226 |
| Amgen Inc. | 4 | $186 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $145 |
| Lilly USA, LLC | 4 | $102 |
| Kowa Pharmaceuticals America, Inc. | 3 | $74 |
| ABBVIE INC. | 2 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $51 |
| Exact Sciences Corporation | 3 | $45 |
| Mannkind Corporation | 1 | $43 |
Products named: AIRSUPRA, AREXVY, BIJUVA, REPATHA, BREZTRI, MOUNJARO, TRELEGY ELLIPTA, ZORYVE.
Industry payments across CA — which companies pay providers there.
